Prescription drug · ANDA
Ropinirole NDC 0228-3640
Ropinirole hydrochloride 6 mg/1 · Tablet, Film coated, Extended release · Oral · Actavis Pharma, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0228-3640-03 | 0022836400300228364003 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0228-3640-03)Marketed from Aug 23, 2012 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ropinirole
- Generic name (nonproprietary)
- ropinirole
- Active ingredients
- Ropinirole hydrochloride — 6 mg/1
- Dosage form
- Tablet, Film coated, Extended release
- Route
- Oral
- Labeler
- Actavis Pharma, Inc.NDC labeler code 0228
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090869
- Marketing start
- Listing expires
- Other FDA classes
- Dopamine Agonists (Mechanism)
- Identifiers
- Product ID 0228-3640_3499549d-d3ad-4636-8234-2539c0fbfac1SPL ID 3499549d-d3ad-4636-8234-2539c0fbfac1SPL set ID 300946bf-2f83-471d-868d-9820b65c52bbRxCUI 799054, 799055, 799056, 824959, 848582UNII D7ZD41RZI9
- Pharmacologic class
- Nonergot Dopamine Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400228364003followed by a unit qualifier and the quantityPackage 00228-3640-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Ropinirole extended-release tablets are indicated for the treatment of Parkinson’s disease. Ropinirole extended-release tablets are a non-ergoline dopamine agonist indicated for the treatment of Parkinson’s disease. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 0228-3640
- What is NDC 0228-3640?
- 0228-3640 is the product NDC for Ropinirole, Ropinirole hydrochloride 6 mg/1 tablet, film coated, extended release, listed with the FDA by Actavis Pharma, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Ropinirole.
- What is the active ingredient?
- Ropinirole hydrochloride.
- Who is the labeler?
- Actavis Pharma, Inc., NDC labeler code 0228. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Ropinirole?
- 110 other product NDCs are listed under this name. See all Ropinirole NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Ropinirole products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| ropinirole | Ropinirole hydrochloride 2 mg/1 | Tablet, Film coatedOral | Preferred Pharmaceuticals Inc. | 68788-4138 | 68788-4138-03 |
| Ropinirole | Ropinirole hydrochloride 2 mg/1 | Tablet, Extended releaseOral | Elite Laboratories, Inc. | 64850-250 | 64850-0250-30 |
| Ropinirole | Ropinirole hydrochloride 4 mg/1 | Tablet, Extended releaseOral | Elite Laboratories, Inc. | 64850-251 | 64850-0251-30 |
| Ropinirole | Ropinirole hydrochloride 6 mg/1 | Tablet, Extended releaseOral | Elite Laboratories, Inc. | 64850-252 | 64850-0252-30 |
| Ropinirole | Ropinirole hydrochloride 8 mg/1 | Tablet, Extended releaseOral | Elite Laboratories, Inc. | 64850-253 | 64850-0253-30 |
| Ropinirole | Ropinirole hydrochloride 12 mg/1 | Tablet, Extended releaseOral | Elite Laboratories, Inc. | 64850-254 | 64850-0254-30 |
| Ropinirole | Ropinirole hydrochloride 2 mg/1 | Tablet, Extended releaseOral | Bryant Ranch Prepack | 72162-2602 | 72162-2602-0372162-2602-09 |
| Ropinirole | Ropinirole hydrochloride 4 mg/1 | Tablet, Extended releaseOral | Bryant Ranch Prepack | 72162-2603 | 72162-2603-0372162-2603-09 |
| Ropinirole | Ropinirole hydrochloride 6 mg/1 | Tablet, Extended releaseOral | Bryant Ranch Prepack | 72162-2604 | 72162-2604-0372162-2604-09 |
| Ropinirole | Ropinirole hydrochloride 8 mg/1 | Tablet, Extended releaseOral | Bryant Ranch Prepack | 72162-2605 | 72162-2605-0372162-2605-09 |
Other NDCs under ANDA 090869
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Ropinirole | Ropinirole hydrochloride 2 mg/1 | Tablet, Film coated, Extended releaseOral | Actavis Pharma, Inc. | 0228-3658 |
| Ropinirole | Ropinirole hydrochloride 4 mg/1 | Tablet, Film coated, Extended releaseOral | Actavis Pharma, Inc. | 0228-3659 |
| Ropinirole | Ropinirole hydrochloride 8 mg/1 | Tablet, Film coated, Extended releaseOral | Actavis Pharma, Inc. | 0228-3660 |
| Ropinirole | Ropinirole hydrochloride 12 mg/1 | Tablet, Film coated, Extended releaseOral | Actavis Pharma, Inc. | 0228-3661 |
| Ropinirole Hydrochloride | Ropinirole hydrochloride 2 mg/1 | Tablet, Film coated, Extended releaseOral | AvKARE | 42291-713 |
| Ropinirole Hydrochloride | Ropinirole hydrochloride 4 mg/1 | Tablet, Film coated, Extended releaseOral | AvKARE | 42291-714 |
| Ropinirole Hydrochloride | Ropinirole hydrochloride 6 mg/1 | Tablet, Film coated, Extended releaseOral | AvKARE | 42291-715 |
| Ropinirole Hydrochloride | Ropinirole hydrochloride 8 mg/1 | Tablet, Film coated, Extended releaseOral | AvKARE | 42291-716 |
| Ropinirole Hydrochloride | Ropinirole hydrochloride 12 mg/1 | Tablet, Film coated, Extended releaseOral | AvKARE | 42291-717 |